Clinical trial
Valdecoxib in Treating Chronic Pain in Cancer Patients
NCT00021996 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00021996 |
|---|---|
| Title | Valdecoxib in Treating Chronic Pain in Cancer Patients |
| Official title | Clinical Protocol for a Randomized Double-Blind, Placebo-Controlled Comparison of the Analgesic Activity of Valdecoxib (SC-65872) 40mg BID as Add-On Therapy to Opioid Medication in Patients With Chronic Cancer Pain |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pain, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | valdecoxib |
| Start date | Jan 1, 2001 |
| Completion | Feb 1, 2004 |
| First posted | Feb 27, 2004 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: